BioNTech (Germany) Market Value
| 22UA Stock | EUR 103.00 4.40 4.46% |
| Symbol | BioNTech |
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 10/30/2023 |
| 11/23/2024 |
If you would invest 0.00 in BioNTech on October 30, 2023 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 390 days. BioNTech is related to or competes with Moderna, CureVac NV, Nel ASA, BYD Company, and Powercell Sweden. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseas... More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.13 | |||
| Information Ratio | 0.0832 | |||
| Maximum Drawdown | 26.8 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 6.63 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.0974 | |||
| Jensen Alpha | 0.4627 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | 0.1043 | |||
| Treynor Ratio | (3.49) |
BioNTech SE Backtested Returns
BioNTech appears to be very steady, given 3 months investment horizon. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We have found thirty technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please makes use of BioNTech's Mean Deviation of 2.48, downside deviation of 3.13, and Risk Adjusted Performance of 0.0974 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioNTech holds a performance score of 9. The firm shows a Beta (market volatility) of -0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioNTech are expected to decrease at a much lower rate. During the bear market, BioNTech is likely to outperform the market. Please check BioNTech's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether BioNTech's price patterns will revert.
Auto-correlation | -0.63 |
Very good reverse predictability
BioNTech SE has very good reverse predictability. Overlapping area represents the amount of predictability between BioNTech time series from 30th of October 2023 to 12th of May 2024 and 12th of May 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of -0.63 indicates that roughly 63.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.63 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 155.17 |
BioNTech SE lagged returns against current returns
Autocorrelation, which is BioNTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioNTech's stock expected returns. We can calculate the autocorrelation of BioNTech returns to help us make a trade decision. For example, suppose you find that BioNTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioNTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioNTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioNTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioNTech stock over time.
Current vs Lagged Prices |
| Timeline |
BioNTech Lagged Returns
When evaluating BioNTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioNTech stock have on its future price. BioNTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioNTech autocorrelation shows the relationship between BioNTech stock current value and its past values and can show if there is a momentum factor associated with investing in BioNTech SE.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in BioNTech Stock
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:Check out BioNTech Correlation, BioNTech Volatility and BioNTech Alpha and Beta module to complement your research on BioNTech. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.